Antimicrobial Agents and Chemotherapy · 2019 · 23 citations · 17 references
Two basic structures that carry the <i>bla</i><sub>KPC</sub> gene, the Tn<i>4401</i> transposon and the Tn<i>3</i>-Tn<i>4401</i> chimera, have been identified within and outside China. However, the different <i>bla</i><sub>KPC</sub> expression levels and promoter activities of these two structures are not completely understood. We constructed Tn<i>4401a</i>, Tn<i>4401b</i>, and Tn<i>3</i>-Tn<i>4401</i> chimera recombinants and found that the imipenem (IPM) and meropenem (MEM) MICs for the <i>Escherichia coli</i> transformants carrying the chimera were 2-fold higher than for those carrying Tn<i>4401b</i> but 2-fold lower than for those carrying Tn<i>4401a</i> In addition to the promoter P1, we characterized a novel potential promoter sequence (PX) in the chimera using 5' rapid amplification of cDNA ends (5' RACE), of which the -35 and -10 sequences were TTCAAA and TGAGACAAT, respectively. Although mutation of P1, P2, or PX significantly downregulated <i>bla</i><sub>KPC</sub> mRNA expression in each structure (<i>P</i> < 0.05), the P2 mutation resulted in 2- and 3-fold greater decreases than the P1 mutation in Tn<i>4401a</i> and Tn<i>4401b</i>, respectively. Similarly, despite no significant difference in the PX and P1 mutations in the chimera, the carbapenem MIC and <i>Klebsiella pneumoniae</i> carbapenemase (KPC) production resulting from P2 mutations were significantly lower than those of P1 (<i>P</i> < 0.01) in the Tn<i>4401</i> transposons. These studies indicate that the Tn<i>3</i>-Tn<i>4401</i> chimera contains a novel potential <i>bla</i><sub>KPC</sub> promoter, PX, and that its carbapenem resistance falls in between those of Tn<i>4401a</i> and Tn<i>4401b</i>.
17